K140490

Substantially Equivalent

CIVA SHEET PD-103

Applicant: Civatech Oncology, Inc.
Product code: KXK
Advisory panel: Radiology
Date received: 2014-02-27
Decision date: 2014-08-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mt. Airy, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.